Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in Japan

Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are extensively used in the treatment of non-small cell lung cancer (NSCLC); hence, equal access to them is important. Therefore, this study aimed to identify regional differences in the prescription of EGFR-TKIs and the factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumoto, Hiromi, Kobayashi, Nobuaki, Shinoda, Satoru, Goto, Atsushi, Kaneko, Ayami, Fukuda, Nobuhiko, Kamimaki, Chisato, Kubo, Sousuke, Watanabe, Keisuke, Horita, Nobuyuki, Hara, Yu, Ishikawa, Yoshihiro, Kaneko, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063675/
https://www.ncbi.nlm.nih.gov/pubmed/36997606
http://dx.doi.org/10.1038/s41598-023-31856-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063675/
https://www.ncbi.nlm.nih.gov/pubmed/36997606
http://dx.doi.org/10.1038/s41598-023-31856-6

Ejemplares similares